Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 16, 2023
Anti-Inflammatories in the Treatment of Dry Eye Disease: A ReviewVictor L Perez, Francis S Mah, Mark Willcox, et al.
Human Gene Therapy|July 17, 2012
Gene therapy approaches for lysosomal storage disease: next-generation treatmentBarry J Byrne, Darin J Falk, Nathalie Clément, et al.
Genetic Vaccines and Therapy|October 16, 2008
Relative persistence of AAV serotype 1 vector genomes in dystrophic muscleChristina A Pacak, Thomas Conlon, Cathryn S Mah, et al.
Cornea|November 1, 2002
Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularizationY Jerold Gordon, Rupinder K Mann, Tammy S Mah, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 23, 2010
An independent in vitro comparison of povidone iodine and SteriLidDrew R Chronister, Regis P Kowalski, Francis S Mah, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 27, 2015
An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infectiveRegis P Kowalski, Eric G Romanowski, Kathleen A Yates, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 28, 2003
The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit modelsY Jerold Gordon, Kathleen A Yates, Francis S Mah, et al.
Ophthalmic Genetics|May 20, 1998
A practice-based survey of familial age-related maculopathyM R Keverline, T S Mah, P O Keverline, et al.
Pageof 13